Experience with phlebography in acute deep vein thrombosis and after its treatment.
D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003973:Diatrizoate / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005017:Ethyl Biscoumacetate / Q000627:therapeutic use; D005268:Femoral Vein / Q000000981:diagnostic imaging; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007084:Iliac Vein / Q000000981:diagnostic imaging; D007275:Injections, Intravenous; D008875:Middle Aged; D010653:Phenylbutazone / Q000008:administration & dosage / Q000627:therapeutic use; D010690:Phlebography; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000000981:diagnostic imaging* / Q000188:drug therapy; D013977:Tibia / Q000098:blood supply; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D005017:Ethyl Biscoumacetate; D003973:Diatrizoate; D006493:Heparin; D013300:Streptokinase; D010653:Phenylbutazone